CVE-2020-16198: philips clinical_collaboration_platform Protection Mechanism Failure
CVSS: 6.3v3.1MediumModified
Published 18-09-2020Last modified 04-06-2025
Vulnerability summary
CVE-2020-16198 is a medium (CVSS 6.3) Protection Mechanism Failure vulnerability in philips clinical_collaboration_platform. EPSS estimates a 0.56% chance of exploitation in the next 30 days, higher than 46% of scored vulnerabilities.
CVSS score
6.3/10
010
Medium · v3.1 (NVD)EPSS score
0.56%
0%100%
Low · 0.00 pp in 30 daysKEVNot listedIn no KEV catalog
RansomwareNone recordedNo known use recorded
Public exploits0No public exploits recorded
Timeline
- 18-09-2020PublishedVulnerability first disclosed.
- 04-06-2025Last modifiedVulnerability information updated.
Description
When an attacker claims to have a given identity, Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, does not prove or insufficiently proves the claim is correct.
CVSS metrics
3 scores · 2 sources · 2 versionsMedium 6.3Preferred score · NVD (NIST)
CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:LSources2 sources · 5.0–6.3
- CVE.orgCNA5.0MediumCVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:U/C:L/I:L/A:LDiffers
Medium 5.8Preferred score · NVD (NIST)
AV:A/AC:L/Au:N/C:P/I:P/A:PSourcesSingle source
EPSS trend
Probability
0.56%
Chance of exploitation in the next 30 days
Percentile
46%
Versus all other CVEs
30-day change
0.00 pp
From 0.56% on 21-09-2026
21-09-202621-10-2026
EPSS score0.56%
Known exploited
Compare KEV catalogsNot in any of the 3 tracked catalogs.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root causeAffected systems
Philips1 product
- clinical_collaboration_platform< 12.2.1 | ≤ 12.2.1
1 vendor · 1 product
References
2 links- us-cert.cisa.gov/ics/advisories/icsma-20-261-01X Refsource MISCThird Party AdvisoryUS Government Resource